Second is in The Lancet: Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trial: https://t.co/6JccQYsIHo https://t.co/vLDkW4yMjT
Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trial.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Apr 2025 – Sep 2025Where it's discussed
-
X / Twitter1 posts
-
YouTube1 videos
AI synopsis
What people are saying
Many posts explore the implications of the study, with expressions like 'this could change treatment protocols' indicating broad interest and appreciation for the research's significance, supported by mentions of the clinical decision rules and the robustness of the data. The variation in tone—from cautious optimism to critical reflection—reflects diverse levels of engagement and perceived impact across different users.
Most discussions acknowledge the validity of the findings, with some emphasizing the importance of optimizing antibiotic durations.
The topic clearly captures interest, as evidenced by comments highlighting the significance of treatment duration and implications for patient care.
Participants reference specific study details, models used, and potential clinical implications, indicating moderate engagement.
While some recognize the study’s potential to influence clinical practices, others focus on confirming existing guidelines, leading to moderate impact scores.
Abstract in brief
- The BALANCE trial found that a 7-day antibiotic treatment for uncomplicated non-bacterial bloodstream infections is just as effective as a 14-day treatment, but the researchers wanted to see if specific patient groups might still benefit from longer treatment.
- They analyzed data from 3,581 patients using various clinical decision rules to assess the impact of treatment duration on 90-day mortality, but none of the rules showed significant differences between the two treatment durations for different risk groups.
- Overall, the study concluded that the 7-day treatment is adequate for most patients, as the clinical decision rules did not identify any subgroup that would benefit from extending treatment to 14 days.
Top posts
Most liked on X and BlueskyAll mentions
BALANCE Trial: Optimal Antibiotic Duration for Bacteremia Outcomes
In this episode, hosts Erin McCreary and Angela Huttner discuss the BALANCE trial, examining the effectiveness of a 7-day antibiotic treatment versus 14 days for uncomplicated gram-negative bacteremia. With insights…
Second is in The Lancet: Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trial: https://t.co/6JccQYsIHo https://t.co/vLDkW4yMjT